Resources
Insights into thepharmacy spend problem.
Articles, guides, and analysis on manufacturer-direct pharmacy, on-benefit pricing, and fiduciary compliance for self-funded employers.
Drug Benefit Integrity (DBI): The Five-Requirement Standard
An independent standard with five structural requirements for ensuring pharmacy benefit decisions are made in the plan's interest.
Read more →Direct-to-Employer Drug Programs (DTE): What Employers Need to Know
Manufacturers are going direct. Learn what DTE means, how it works, and what infrastructure is required to bring these programs inside the benefit.
Read more →What Is Lowest Net Cost Prescription Routing?
Every plan sponsor wants the lowest net cost. Here is what the term actually means and why it matters across all channels.
Read more →PBM Fiduciary Compliance: How Employers Can Prove Prudent Oversight
CAA 2026, the DOL proposed rule, and ERISA litigation are raising the bar. A practical guide to demonstrating fiduciary prudence.
Read more →What Is a Direct-to-Employer Pharmacy Benefit Program?
How self-funded employers access manufacturer-direct drug pricing inside the benefit, without routing around the PBM.
March 31, 2026
Read more →How Manufacturers Can Launch a Direct-to-Employer Drug Program
Launching a manufacturer direct channel takes more than pricing. The operational infrastructure required to make DTE work inside a benefit.
April 1, 2026
Read more →ERISA, CAA, and the Self-Funded Employer's Duty to Evaluate Direct Drug Channels
CAA 2026 raised the bar for pharmacy benefit oversight. Self-funded employers now face personal liability for decisions they cannot document.
April 2, 2026
Read more →Manufacturer Direct vs. PBM for GLP-1s: What's the Actual Cost?
PBMs report low net GLP-1 costs. Manufacturers offer direct pricing. How to compare the two channels and what employers actually pay.
April 4, 2026
Read more →What Benefits Consultants Need to Know About Manufacturer-Direct Pharmacy Programs
Manufacturer-direct pharmacy programs are reaching employer conversations fast. What the model requires and how to evaluate it for clients.
April 7, 2026
Read more →How to Evaluate a Direct-to-Employer Pharmacy Platform: Five Questions to Ask
Not all direct-to-employer platforms are equivalent. Five structural questions that separate real infrastructure from cash-pay workarounds.
April 8, 2026
Read more →ERISA Fiduciary Duty and Pharmacy Benefits: What Every Self-Funded Employer Must Know in 2026
Plan fiduciaries face personal liability for pharmacy decisions. What the prudent expert standard requires and how to demonstrate compliance.
April 9, 2026
Read more →How to Evaluate PBM Fiduciary Alignment: A Practical Guide for Plan Sponsors
What genuine fiduciary alignment requires, how to evaluate your current PBM against that standard, and what to do when it falls short.
April 10, 2026
Read more →CAA 2026 and Pharmacy Benefits: What Self-Funded Employers Must Do Now
CAA 2026 created new PBM disclosure requirements, rebate pass-through mandates, and fiduciary obligations. What changed and what plan sponsors must do.
April 11, 2026
Read more →How to Audit Your PBM: A Practical Action Guide for Self-Funded Employers
Most self-funded employers have never audited their PBM. Under ERISA and CAA 2026, that is a fiduciary risk. A step-by-step guide.
April 12, 2026
Read more →